跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MINT-SOLIFENACIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MINT-SOLIFENACIN
Authorized
STANDARD
MINT-SOLIFENACIN
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b13c437d29456950
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
b13c437d29456950
Drug Approval Canada Name
MINT-SOLIFENACIN
Product Name
MINT-SOLIFENACIN
Status
Cancelled Post Market
Status Date
2019-11-20
Original Market Date
2016-04-20
Din
02443198
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
86:12.04
Atc Original
G04BD08 SOLIFENACIN
Atc Name
g 04 bd 08
Aig Number
0151584002
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
SOLIFENACIN SUCCINATE
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b13c437d29456950
Type
Standard
Back to Health Canada Approvals